CPHI Worldwide, 4-6 October Barcelona, Spain, Fira Barcelona

Have you heard about the new GDP guidelines for excipients?

Visit our stand 5B1 or book a meeting with our experts at hnap@novonordiskpharmatech.com, who can tell you about the latest regulatory developments implemented at Novo Nordisk Pharmatech A/S – for example the new European Good Distribution Practices Guidelines for APIs, the new Guidelines on the formalised risk assessment for appropriate GMP for excipients and the ICH Q3D requirements for Elemental Impurities.

BioProcess International, 4-7 October Boston MA, USA, Boston convention and exhibition center

Are you looking to optimize your cell density and viability?

Insulin might play an important role in your cell culture media. Our recombinant insulin is a key component in serum free growth media for mammalian cells. It is used for the manufacturing of monoclonal antibodies, virus vaccines, gene therapy products and many other biological drug products approved by regulatory bodies worldwide, including FDA and EMA. Stop by our booth #1138 for a talk how insulin could play an important role in your upstream process and for the chance to win an Amazon kindle.